LLY stock news | Eli Lilly & Co latest news - TipRanks - TipRanks.com
Published 1 day ago• 1 minute read
PremiumRatingsEli Lilly & Co: Strategic Growth Through VERV Acquisition and Pioneering Gene Editing
Eli Lilly (LLY) Enters Gene-Editing Space with Verve Therapeutics Acquisition
SanDisk initiated, Analog Devices upgraded: Wall Street’s top analyst calls
PremiumThe FlyVideo: Verve, solar stocks among major pre-market movers
Eli Lilly to acquire Verve Therapeutics for $10.50 per share in cash
M&A News: Verve Therapeutics Stock (VERV) Rallies 75% on News of Potential Acquisition by Eli Lilly
PremiumMarket NewsUBS Reiterates Buy Rating on Eli Lilly Stock (LLY) and Lauds Pricing Strategy
Senators to propose ban on drug ads to consumers, WSJ reports
RFK Jr. names eight members to vaccine panel, WSJ reports
Loading...
Loading...
You may also like...
Loading...
